0001209191-18-029966.txt : 20180514 0001209191-18-029966.hdr.sgml : 20180514 20180514175030 ACCESSION NUMBER: 0001209191-18-029966 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180221 FILED AS OF DATE: 20180514 DATE AS OF CHANGE: 20180514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tambi Brian CENTRAL INDEX KEY: 0001467848 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35902 FILM NUMBER: 18832198 MAIL ADDRESS: STREET 1: 1925 WEST FIELD COURT SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Insys Therapeutics, Inc. CENTRAL INDEX KEY: 0001516479 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510327886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 BUSINESS PHONE: 602-910-2617 MAIL ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-21 0 0001516479 Insys Therapeutics, Inc. INSY 0001467848 Tambi Brian C/O INSYS THERAPEUTICS, INC. 1333 SOUTH SPECTRUM BLVD, SUITE 100 CHANDLER AZ 85286 1 0 0 0 Common Stock 2018-02-21 4 A 0 4000 0.00 A 4000 D Common Stock 2018-05-10 4 M 0 33654 0.61 A 37654 D Common Stock 2018-05-10 4 M 0 68850 1.62 A 106504 D Common Stock 2018-05-10 4 M 0 60000 3.63 A 166504 D Common Stock 2018-05-10 4 S 0 166504 6.41 D 0 D Restricted Stock Units 2018-02-21 4 D 0 4000 0.00 D Common Stock 4000 0 D Stock Option (right to buy) 0.61 2018-05-10 4 M 0 33654 0.00 D 2020-02-21 Common Stock 33654 0 D Stock Option (right to buy) 1.62 2018-05-10 4 M 0 68850 0.00 D 2021-03-28 Common Stock 68850 0 D Stock Option (right to buy) 3.63 2018-05-10 4 M 0 60000 0.00 D 2023-05-13 Common Stock 60000 0 D The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.61 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units ("RSUs") vested on the one year anniversary of the date of grant. The exercise price reflects a 3-for-2 forward stock split effected by the Issuer on March 28, 2014 and a 2-for-1 forward stock split effected by the Issuer on June 5, 2015. The option is fully vested and exercisable. /s/ Brian Tambi 2018-05-11